Wrapping Up 2014..


In January 2015, this blog will be 8 years old. I have blogged consistently during that time  with genuine conviction, about issues which I think are extremely important, but in particular, I have drawn attention to GSK’s unethical promotion of their dangerous and defective anti-depressant, Seroxat (Paxil). However, as anyone can see, from reading the hundreds of posts on this blog, GSK’s sinister activities have gone far beyond Seroxat marketing, bogus drugs and deception.

I will be wrapping up this blog by the end of the year, and I don’t plan to post anything after January 2015, 8 years is enough I think, I have done more than my fair share, and maybe it’s time for others to do their bit. I will leave the blog online though, as I think it’s an extremely important resource, for researchers, patients etc.

Furthermore, I was recently contacted by an anonymous source who is seeking information on GSK and Burroughs Wellcome (a previous incarnation of the company) and their involvement in possible illegal and unethical vaccine trials on Irish orphans. If anyone out there has any information on these trials or anything related to them, can you contact me on truthman30@gmail.com and I will pass on the relevant details to the researchers.

In particular, some of the information sought is in regards to the following issues:

  1. Were there additional trials in Ireland?
  2. Were there similar trials in England or elsewhere in the world?
  3. Is there any evidence of money changing hands between the government/health boards/religious orders and the pharmaceutical companies?
  4. Can any inference be drawn from the way the Vaccine Trials Division of the Commission of Inquiry Into Child Abuse was shut down and the Government relationship with GSK?

 

If anyone out there has any information on any of the above, or anything that they feel might be of use in getting to the bottom of these drug trials on Irish orphans, contact me on the e-mail provided, through twitter, or leave a comment.

I won’t be doing any more posting after Christmas, as to be honest, it’s just too time consuming and not feasible to blog anymore. I also had a recent personal experience that I found very disturbing. I won’t go into details about this horrendous event, but what I will say is, I am more than capable of defending myself, but I refuse to respond to bully boy tactics, and veiled threats, I abhor that kind of behavior, and I always disengage when bullies try those tactics on me. The experience was related to this blog and the value of the work I do, and this onerous episode has really been the catalyst for making the decision to give up blogging. Writing a blog, and dealing with the stuff I research, really can be a thankless, lonely role,  at times. However I don’t regret one minute of it, or one post I made, as I know now I have made a  huge difference and the truth is now self evident, and that was the point…

Thanks for reading..

Ian Hudson Bumbles His Way Through A Grilling In A Tamiflu Inquiry


If you want to see how people like the MHRA’s Ian Hudson run rings around public inquiries in regards to dubious drugs (in this case Roche’s Tamiflu) check out this recent video on the Tamiflu debacle.

It”s all very monty python-esque, and in true British style, nobody is held to account for a waste of over half a billion of UK tax-payers money on a useless drug for a fake pandemic..

 At least he turned up to this inquiry I suppose, because he didn’t bother to turn up to the Seroxat inquiry many years ago and the explanation for his absence was even more dubious than a dose of Tamiflu or Seroxat…

http://seroxatsecrets.wordpress.com/2009/06/15/mhra-and-ian-hudson-still-questions-to-be-answered/

The strange thing is that on the day the House of Commons Health Select Committee wanted to hear evidence from the MHRA specifically about Seroxat trial data and safety, Professor Alaisdair Breckenridge (MHRA Chairman), Professor Kent Woods (MHRA CEO) and June Raine (MHRA Director of Vigilence and Risk Management) all managed to attend the hearing.

MPs had expected to be able to question Ian Hudsonas well… unfortunately Dr Hudson could not attend as he had a prior engagement.

Scroll to around 17.18.30 on the video and watch Ian Hudson avoid answering questions about Tamiflu.

http://www.parliamentlive.tv/Main/Player.aspx?meetingId=16130


From Bob Fiddaman at Seroxat Sufferers Blog

http://fiddaman.blogspot.ie/2014/10/mhras-ian-hudson-grilled-over-clinical.html?spref=tw

 

Tuesday, October 21, 2014

MHRA’s Ian Hudson Grilled Over Clinical Trial Data

Yesterday [Monday 20 October] UK Parliament broadcast a committee meeting regarding Tamiflu, a prescription medicine used to treat the flu (influenza) in people 2 weeks of age and older.

In January this year, drawing attention to the lack of transparency over the results of clinical trials of the antiviral medicine, stockpiled for use in an influenza epidemic.  The Commons Select Committee concluded that the failure of manufacturers to share the full results of clinical trials with doctors, researchers and clinicians, undermined their ability to make informed decisions about treatments and the use of medicines by the NHS.

Yesterdays meeting probed the lack of transparency further.

It’s very interesting particularly as we can see Chief Executive of the MHRA, Ian Hudson, being grilled by Richard Bacon, MP. Hudson was asked just one question but seemed very reluctant to give any straight forward answers.

Basically, the UK government have claimed that it would not be feasible for the full methods and results of clinical trials to be made available to doctors and other healthcare professionals.

Ian Hudson was asked why he thought it was not feasible.

The exchange between Hudson and Richard Bacon, MP reminded me of David Brent, a fictional character played by Ricky Gervais in The Office. Brent, when questioned about his management methods was always evasive – Hudson’s response to Bacon’s question is so very similar. Whereas Brent speaks of pies and charts, Hudson speaks of Freedom of Information requests and policies…without actually answering the question.

Hudson is being really evasive here, just as he was when giving evidence for GlaxoSmithKline in a video deposition back in 2000. [1]  Hudson, was employed as GlaxoSmithKline’s World Safety Officer before eventually landing his role of CEO of the agency that protects the public from unsafe prescription medication.

Time and time again he avoids the question put to him by Bacon, time and time again Bacon reiterates his question, leaving Hudson to waffle on in the style of David Brent. You can even see a man and a woman at the back of the room laugh at Hudson’s avoidance to answer a simple question.

Kind of ironic that Hudson is being grilled by an MP whose surname is Bacon, doncha think? :-)

Here’s the MHRA’s Ian Hudson playing David Brent yesterday [Skip to 17.44.46] [LINK]

Just like The Office there is no canned laughter.

Now compare with David Brent.

Bob Fiddaman.

GSK Ebola Vaccine: Big pharma has an interest in rich people being sick


http://www.theguardian.com/commentisfree/belief/2014/oct/17/big-pharma-interest-rich-people-sick?CMP=fb_gu#start-of-comments

Big pharma has an interest in rich people being sick

What profit is there in a healthy population? If everyone were healthy, it would be the job of the pharmaceutical companies to persuade us that we were not well
A burial team with the body of an Ebola victim in Monrovia, Liberia. Photograph: Marcus DiPaola/NurP
A burial team with the body of an Ebola victim in Monrovia, Liberia. Photograph: Marcus DiPaola/NurPhoto/Rex

The giant pharmaceutical company GlaxoSmithKline said yesterday that its work on a vaccine for Ebola will “come too late” to do anything about the current situation. Even now it is trying to compress trials that would normally take a decade into a year. The impression it gives is that it is working flat out, no holds barred. But hang on a moment. Ebola was discovered back in 1976. What has GlaxoSmithKline been doing since then? Answer: not much.

A small clue to why can be found by looking at the stock price of Tekmira Pharmaceuticals, the Canadian-based drugs firm that some investors seem to think is leading the pack on Ebola research. Tekmira shares rose a massive 180% from mid-July to October, with most of the share-price action coming when the virus jumped to Europe and the US.

Ebola has been killing people in central and western Africa for at least 38 years – but it’s only when the virus becomes a threat to the developed world that there is seen to be a profit in it. I know it sounds cynical to say it flat out like that – but it sounds cynical because it is. What business case is there for developing drugs to save the lives of poor Africans when they don’t have the money to pay for them? Especially when there is so much more profit to be had in – for instance – giving rich white men erections. As a study in last year’s Lancet showed, of the 336 new drugs developed in the first decade of this century, only four of them were for what are known in jargon as neglected tropical diseases – three for malaria and one for diarrhoea.

The point being this: the business model of market-driven big (or even medium-sized) pharma does not work well to address the challenges posed by a virus that ultimately has no respect for geography or bank balance. Some of the developed world’s early interest in Ebola was in whether it could be weaponised. It was said that the Russian biological weapons unit – Biopreparat – had turned Ebola into an aerosol spray.

All of which is red meat for conspiracy theorists (like those who tell you that the patent for the Ebola virus is owned by the US government, which is true). But my suspicion is not about shady government actions but about basic capitalist economics. Isn’t it interesting that there is money about to ask scientists to turn a virus into a weapon, but not the money about to ask scientists to find a vaccine? And by the time there’s a market for a vaccine, it’s too late.

What better example of what is commonly called market failure – that state of affairs in which market forces do not make for desirable outcomes. Here’s another example: remember Nelson Mandela having to take on the big pharmaceutical companies as thousands of dying South Africans were unable to afford Aids drugs. Apparently, the market-driven economics of health care do not have an answer to a virus that begins in a part of the world where there isn’t much money. And that is often where dangerous viruses begin. Which is precisely why market forces will not be able to save us.

Indeed, on the contrary, market-driven healthcare is incentivised to keep us sick. For what profit is there in a healthy population? If everyone were healthy, it would be the job of the pharmaceutical companies to persuade us that we were not well, that certain things about us needed fixing, putting right (even if they didn’t).

Its a bit like Friedrich Nietzsche’s criticism of the Christian priest: that the priest first has to poison us into imagining we are unwell – and thus in need of saving – before he can present himself as the cure, as salvation. There is no market for salvation in a sinless world. Of course, big pharma presents itself as evidence-based and scientific. Not at all like Nietzsche’s Christianity. But it’s not the science that calls the tune. It is the stock price. And the stock price goes up when rich people feel threatened.

Did Depression Meds Cause Misty Upham To Commit Suicide? (What Meds Was She On?)


http://www.huffingtonpost.co.uk/2014/10/17/misty-upham-dead_n_6002260.html?utm_hp_ref=uk

Misty Upham Dead: Body Of 32-Year-Old ‘Django Unchained’ Actress Found In Ravine

Posted: 17/10/2014 12:45 BST Updated: 17/10/2014 15:59 BST

The family of actress Misty Upham have confirmed she has died after her body was discovered in a ravine near Seattle. She was 32.

A family spokesman for the star, who was best known for her roles in ‘Django Unchained‘ and, more recently ‘August: Osage County‘, confirmed her death on Friday.

misty upham

Misty Upham

Misty, who is understood to have suffered from bipolar disorder, had been missing since 6 October.

Her body and a purse with ID belonging to Upham was found following a search of the area by her friends and family.

Her father, Charles Upham, confirmed the identity of the Native American actress to authorities.

Police Commander Steve Stocker said there was currently no evidence “to believe there is foul play.”

Shortly after her disappearance, her father had expressed concern that his daughter had stopped taking her medication and may have been suicidal.

The actress once described herself as “painfully shy”.

“When I’m in front of the camera, or talking to people as an actress, and not as myself, it’s like I become another person. Somehow possessed with somebody who is worth talking to. Because at home people could care less about what I have to say,” she said.

Upon hearing the news of her death, Meryl Streep – who starred alongside Misty in ‘August: Osage County’, told the Hollywood Reporter: “So, so sad to hear this news — all our thoughts are with her family and with her beautiful spirit.”

Animal welfare organisation, PETA, who Misty was a longtime supporter of also paid tribute to the actress in a statement.

“The world will be a colder place without Misty’s warm heart and she will be sorely missed at PETA,” the statement read. “She was extremely kind and cared deeply about animals; constantly calling for protection for the bears suffering in roadside zoos on tribal land, a call we will carry forward in her honour.

“It’s a tragedy whenever anyone dies before their time, but Misty Upham was a friend to us and to animals everywhere.”

Sir Andrew Witty, Wellbutrin (Zyban/Bupropion) Marketing, And The Mystery Of Lauren Stevens…


Some very very interesting discoveries and posts on the way…

But for now…

These…

mySuperLamePic_d9d3dee0c6e176c297da77f3f3ea0702

http://www.docguide.com/glaxosmithkline-receives-first-european-approval-wellbutrin-xr-r-bupropion-hydrochloride-modified-re


Source: Blood  |  Posted 7 years ago

GlaxoSmithKline Receives First European Approval for Wellbutrin XR(R) (Bupropion Hydrochloride Modified-Release Tablets)

Marketing license granted in Netherlands for adult patients with depression

LONDON, UK — January 16, 2007 — GlaxoSmithKline announced today that Wellbutrin XR?* (bupropion hydrochloride modified-release tablets), has been granted a marketing license in The Netherlands for the treatment of adult patients with major depressive episodes. The medicine is also considered approvable by the regulatory agencies of 21 other countries** under the Decentralised Procedure.

Wellbutrin XR is the first once-daily noradrenaline dopamine reuptake inhibitor (NDRI) approved for the treatment of Major Depressive Disorder (MDD) in Europe. 1,2,3 Uniquely targeting dopamine and noradrenaline (two chemicals in the brain known to be involved in regulating mood) to treat MDD effectively, Wellbutrin XR offers an alternative to currently available treatments, including Selective Serotonin Reuptake Inhibitors (SSRIs) / Serotonin and Noradrenaline Reuptake Inhibitors (SNRIs) which some patients are unable to tolerate due to side effects such as weight gain and sexual dysfunction. 4,5,6,7

“Wellbutrin XR is an important new medicine for doctors and patients in Europe,” comments Andrew Witty, president, GSK Pharmaceuticals, Europe. “Depression can be a crippling condition that is often difficult to treat. With its unique mode of action, Wellbutrin XR offers a real alternative to the depressed patient. We hope its profile will help patients stay on their therapy, which would address a significant unmet need in the area of antidepressants.”

Wellbutrin XR is available as a 300mg or 150mg tablet with a dose of up to 300mg once daily starting with 150mg once daily.

Nearly 13 million patients have been treated with Wellbutrin XR in the USA where it is known as Wellbutrin XL *** and was FDA approved in 2003.5

It is expected that regulatory agencies in various European countries will grant national licenses for Wellbutrin XR throughout the first quarter of 2007, and the medicine could begin to be available to patients from April 2007.

GlaxoSmithKline has an agreement with Biovail Corporation for worldwide sales and distribution of bupropion hydrochloride modified-release tablets.

The most common side effects observed in clinical trials with Wellbutrin XR were trouble sleeping, headache, dry mouth, and upset stomach (nausea and vomiting).8

There is a risk of seizure with Wellbutrin XR, which increases with higher doses. People should not use it if they have had a seizure or eating disorder, or if they abruptly stop using alcohol or sedatives. People should not take Wellbutrin XR with monoamine oxidase inhibitors (MAOIs), or medicines that contain bupropion.

* Wellbutrin XR will be the most common tradename in European countries. Other tradenames include: Elontril (several countries), Voxra (Sweden) and Wellbutrin Retard (Norway).

** Austria, Belgium, Cyprus, Czech Republic, Estonia, Germany, Greece, Hungary, Iceland, Italy, Latvia, Lithuania, Luxembourg, Malta, Norway, Poland, Portugal, Slovakia, Slovenia, Spain, and Sweden.

*** While Wellbutrin XL is approved for the treatment of major depressive disorder in the United States, approved conditions of use and labeling may vary from those in European countries.

REFERENCES:
1. Stahl SM. Essential Psychopharmacology. 2nd ed. New York, NY: CambridgeUniversityPress; 2000.
2. Ascher JA et al. J Clin Psychiatry 1995; 56:395?401.
3. Stahl SM et al. Prim Care Companion J Clin Psychiatry 2004; 6:159?166.
4. Jefferson JW et al., J Clin Psychiatry 2006 June; 67(6):865-873.
5. GSK Data on file.
6. Thase ME et al. J Clin Pharmacol 2006; 26(5): 482-488.
7. Zajecka J. J Clin Psychiatry.2001; 62 Suppl 3:35-43.
8. GSK. Wellbutrin XR European Summary of Product Characteristics. 2007.

SOURCE: GlaxoSmithKline


http://adage.com/article/news/experience-pays-glaxo-wellcome-wins-consumers-pharmaceuticals-relationship-building-makes-difference/70483/

As direct-to-consumer prescription drug advertising continues to evolve, the No. 1 spender in DTC is evolving with it.

When the Food & Drug Administration relaxed its rules for prescription drug ads on TV in August, Glaxo Wellcome was ahead of the pack. Under the marketing stewardship of VP-General Manager of Marketing Andrew Witty, the company was first out of the gate with an estimated $10 million network TV buy for its antiviral Valtrex that mentioned both the drug’s name and herpes, the condition.

The spot also led viewers to print ads for full disclosure information.

SWIFT TO ACT

Glaxo’s swiftness was born of experience with DTC advertising and close contact with the FDA prior to the new rules.

“We started experimenting with DTC early and made a relationship with the rulemakers,” says Mr. Witty.

Indeed, Glaxo has been the top advertiser in DTC prescription drug advertising-a business expected to hit $1 billion this year-for two years running. Last year alone, Glaxo’s nasal spray Flonase received $32.7 million in support, migraine remedy Imitrex got $20.4 million, Serevent asthma inhaler had $16.4 million.

Mr. Witty also is adding more product firepower this year with Glaxo’s new anti-smoking pill Zyban getting an estimated $55 million in support (the brand is even getting TV teaser ads prior to its launch). Zithromax, the first antibiotic to receive DTC support, will get an estimated $15 million.

“Patients are demanding more information,” says Mr. Witty, 33. He notes that “one of the key challenges is getting patients to seek help and that’s where DTC comes in. Sometimes people need news, a sense of hope or courage-like with genital herpes-to go to their doctor.”

http://www.fiercepharma.com/story/glaxo-settles-multi-state-label-marketing-probe-105m-fine/2014-06-05

Glaxo settles multi-state off-label marketing probe with $105M fine

GlaxoSmithKline’s ($GSK) latest penalty for improper marketing practices may seem little more than a slap on the wrist–except that it’s coming at the worst possible time for the embattled British drugmaker. GSK agreed to pay $105 million to settle charges in California, New York, Texas and more than 40 other states that it illegally promoted its asthma drug Advair and antidepressants Wellbutrin and Paxil.

The states’ attorneys general alleged that GSK pushed mild asthma sufferers to request Advair even though the FDA did not approve it for mild cases, and that it marketed Wellbutrin and Paxil off-label for use in children.The states also claimed that the company promoted Wellbutrin for other unapproved uses.

Under the terms of the settlement, announced by Illinois attorney general Lisa Madigan, GSK has agreed to reform its marketing practices and refrain from disseminating information related to off-label uses of its drugs. GSK also agreed to continue for 5 years an internal program that “reduces the level of financial incentives by the company to drug sales representatives,” according to Madigan’s statement.


GlaxoSmithKline Anonymous board for GlaxoSmithKline

http://www.cafepharma.com/boards/showthread.php?t=465348

Reply

Bookmark and Share
Thread Tools Rate Thread Display Modes
#1
Old 05-10-2011, 02:24 PM
Anonymous

Posts: n/a

Today the Bush appointed pro-corporation Judge Titus, dismissed the Charges against Lauren Stevens. He will be regreting his foolish actions at a later date. Clear case of Judicial prejudice and malpractice. Wait until he finds out how this company raped the taxpayers and injured/killed patients.

The good news is that according to the company the main investigation on all 9 main GSK drugs is in Boston. If I am correct the DOJ criminal attorney there is Susan Winkler, she is a pit bull.
Stevens will now be indicted on the main crimes she committed including coverup of illegal activities, payments of kickbacks to physicians and a vast conspiracy of off label detailing that included 9 drugs, all under her watch. She will be indicted this time, the Judge in Boston is legitimate, put it that way.

It was definitely proven at the trial that GSK knowingly did two things….and these were with all the drugs.

1) They detailed off label…just look at all the call reports, which Stan Hull later did away with, and ALL the Wellbutrin, Paxil, Imitrex, Lamictal, Valtrex etc. They covered up everything and it goes all the way to the top.

2) They paid kickbacks and gave quid pro quos to some 49,000 speakers on the speakers bureau. We saw it all.

This was a narrow case on one small subject, hiding Wellbutrin slides from 2 Docs, What about the other thousands that had the same slides. Also,what about all the off label slides for other drugs. I saved all those, call me.

When there is a trial in Boston, there will be criminal and civil convictions. The company will be barred from all Federal programs, and if the appropriate penalties apply will be bankrupt.

Tell all the mothers who have deformed babies, or children that killed themselves with Paxil and other drugs. The Judge did not know of that misconduct, which is huge. He will be proven the fool that he is, and a disgrace to the bench, and it does not end there.

In the meantime, according to GSK attorneys who illegally broadcast an FCA case on their website, for profit-we know who you are,…and GSK who admits there is an 8 year investigation ongoing in Boston….hold on to your seatbelts, this company is in for a crash landing.

Hopefully soon.

Old 05-13-2011, 09:21 PM
Anonymous
Posts: n/a
Lightbulb Re: Great news on Stevens trial

They also showed CEO Witty was in on marketing sscams in the late 90’s and had to lie and coverup.How Much do you think they paid the same speakers when he was there ? Sorry Witty, also big mistake paying of Ingram to be you Advisor in chief in Jan 2010. Corrupt to the core and in on it all. Pretty disgusting, but as stated before Justice will prevail in spite of this small FDA case that would have gone against Stevens, unless she had a uniformed fool for a Judge who will regret how he hurt patients and taxpayers. Recall the SOB, fools like that do not belong making decisions for juries…especially the THIRD jury. The prosecutor in the case Sara Bloom is a patriot..Titus is a corrupt fool.

Oh and did you notice they shot the messenger, fired them after they came forward with slides and named all the off label crap going on -9 drugs, they say beginning in Co.- now in Mass.—-Titus is an embarrasment to the bench. It will be proven.

Political hack. End of story (for now).

Old 05-13-2011, 09:21 PM
Anonymous
Posts: n/a
Lightbulb Re: Great news on Stevens trial

They also showed CEO Witty was in on marketing sscams in the late 90’s and had to lie and coverup.How Much do you think they paid the same speakers when he was there ? Sorry Witty, also big mistake paying of Ingram to be you Advisor in chief in Jan 2010. Corrupt to the core and in on it all. Pretty disgusting, but as stated before Justice will prevail in spite of this small FDA case that would have gone against Stevens, unless she had a uniformed fool for a Judge who will regret how he hurt patients and taxpayers. Recall the SOB, fools like that do not belong making decisions for juries…especially the THIRD jury. The prosecutor in the case Sara Bloom is a patriot..Titus is a corrupt fool.

Oh and did you notice they shot the messenger, fired them after they came forward with slides and named all the off label crap going on -9 drugs, they say beginning in Co.- now in Mass.—-Titus is an embarrasment to the bench. It will be proven.

Political hack. End of story (for now).

View Full Version : Trial not just about weight loss-this involves

Anonymous
04-28-2011, 12:45 PM
The active detailiing of Wellbutrin to pregnant women (birth defects), the detailing of Wellbutrin for kids, ADHD, bipolar, anxiety and more with death and/oer damaging results. The waste of Medicare dollars as an ‘impotency’ drug for all men and women. The paying of kickbacks to thousands of physicians to lecture off label at luxurious resorts. The weight loss portion is small, Stevens knows that and so does everyone else at GSK. We were trained and had to pass a test on weight loss in non depressed patients. Stevens is a fucking criminal in on much more than taking the bullet for GSK. Just wait

4. Feds: Ex-GSK lawyer put loyalty above law
By Tracy Staton Comment | Forward | Twitter | Facebook | LinkedIn

Former GlaxoSmithKline attorney Lauren Stevens didn’t get much of a reprieve after her first indictment was tossed out last month. The government quickly indicted her again–on obstruction charges, among others–and, starting yesterday, took their case to trial.

Justice Department lawyers say Stevens tried to cover up potential marketing violations at GSK. When government investigators came calling, she responded by making false statements about the company’s promotions of the antidepressant Wellbutrin, they maintain. She also failed to disclose some questionable marketing practices and didn’t turn over potentially incriminating promotional materials, the indictment says.

“This is a case about a lawyer who put loyalty to her company above fidelity to the truth and to the law,” prosecutor Patrick Jasperse said during opening statements in a Maryland federal court (as quoted by Bloomberg). “This is a case about a lawyer who went too far, from aggressively representing her company to breaking the law.”

Stevens’ attorney told the jury she didn’t intend to mislead the FDA about Wellbutrin marketing. She responded to the investigation as advised by in-house counsel at GSK and by outside law firm King & Spalding, attorney Reid Weingarten said. “Everything she did in this case was utterly inconsistent with an intent to deceive the government,” he said.

Anonymous
04-29-2011, 07:07 AM
If you have something, become a whistle blower. What classes did you ever take and what test? No such thing. It’s obvious you hate GSK. No one I know promoted Wellbutrin for weight loss. A good friend of mine is an MD that owns a comprehensive weight management practice. The only time he ever used any antidepresseants were when patients exhibited signs and symptoms of depression or disthymia. Hire a lawyer and grind your axe in court if you really have something.

The active detailiing of Wellbutrin to pregnant women (birth defects), the detailing of Wellbutrin for kids, ADHD, bipolar, anxiety and more with death and/oer damaging results. The waste of Medicare dollars as an ‘impotency’ drug for all men and women. The paying of kickbacks to thousands of physicians to lecture off label at luxurious resorts. The weight loss portion is small, Stevens knows that and so does everyone else at GSK. We were trained and had to pass a test on weight loss in non depressed patients. Stevens is a fucking criminal in on much more than taking the bullet for GSK. Just wait

4. Feds: Ex-GSK lawyer put loyalty above law
By Tracy Staton Comment | Forward | Twitter | Facebook | LinkedIn

Former GlaxoSmithKline attorney Lauren Stevens didn’t get much of a reprieve after her first indictment was tossed out last month. The government quickly indicted her again–on obstruction charges, among others–and, starting yesterday, took their case to trial.

Justice Department lawyers say Stevens tried to cover up potential marketing violations at GSK. When government investigators came calling, she responded by making false statements about the company’s promotions of the antidepressant Wellbutrin, they maintain. She also failed to disclose some questionable marketing practices and didn’t turn over potentially incriminating promotional materials, the indictment says.

“This is a case about a lawyer who put loyalty to her company above fidelity to the truth and to the law,” prosecutor Patrick Jasperse said during opening statements in a Maryland federal court (as quoted by Bloomberg). “This is a case about a lawyer who went too far, from aggressively representing her company to breaking the law.”

Stevens’ attorney told the jury she didn’t intend to mislead the FDA about Wellbutrin marketing. She responded to the investigation as advised by in-house counsel at GSK and by outside law firm King & Spalding, attorney Reid Weingarten said. “Everything she did in this case was utterly inconsistent with an intent to deceive the government,” he said.

Anonymous
04-29-2011, 07:51 AM
Now there is some good advice and a lot of bullshit combined. Now, who would want to give up ten years of their life to blow the whistle ? Maybe someone with some balls and brains, unlike your lame ass.
Anonymous
04-29-2011, 10:57 AM
If you have something, become a whistle blower. What classes did you ever take and what test? No such thing. It’s obvious you hate GSK. No one I know promoted Wellbutrin for weight loss. A good friend of mine is an MD that owns a comprehensive weight management practice. The only time he ever used any antidepresseants were when patients exhibited signs and symptoms of depression or disthymia. Hire a lawyer and grind your axe in court if you really have something.

I sold Wellbutrin for years and often sold on the pregnancy category B as well as the weight loss. Also sold a ton on the combination use with an SSRI. None of these were approved messages from marketing but there is only so much you can do with “no sexual side effects.”

When you are threatened monthly with being fired for not pulling up numbers on a drug with no formulary coverage (b/c GSK was selling the generic SR for pennies)- you have to get creative to protect your job so you can feed your family.

Anonymous
04-29-2011, 11:42 AM
I sold Wellbutrin for years and often sold on the pregnancy category B as well as the weight loss. Also sold a ton on the combination use with an SSRI. None of these were approved messages from marketing but there is only so much you can do with “no sexual side effects.”

When you are threatened monthly with being fired for not pulling up numbers on a drug with no formulary coverage (b/c GSK was selling the generic SR for pennies)- you have to get creative to protect your job so you can feed your family.

Everybody did that and more, it was however a marketing plan. We were trained on weight loss in nondepressed patients…tested on studies, Why ? Every DM that rode with reps heard all the off label promotion, they all including marketing and upper level managers saw the call reports…then they went to Write Right (lie on call reports) Simple. Fax backs were a contest to see how many we could get out, whether the doc asked for them or not. Most reps carried copies in their bags, the ones without the not to be used for detailing, which we all got by simply calling in. These were plans by marketing, PRIDE programs and whore speakers were utilized by all to sell of label. Hudziak, Pradko, Montano, and hundreds of others were booked months in advance with off label slides printed by GSK. Are you shitting me ? Getting creative ? everyone was then creative because it was the marketing plan, it was a return on investment with some 50,000m speakers. If they didnot say what they were told, they were dropped. You think you were some kind of rogue rep huh ? LOL

GSK Now Investigating Corruption In United Arab Emirates (UAE)


http://www.reuters.com/article/2014/10/07/us-gsk-emirates-idUSKCN0HW1L420141007

(Reuters) – Drugmaker GlaxoSmithKline, which was slapped with a record $489 million fine for corruption in China last month, said on Tuesday it was looking into allegations of corruption in the United Arab Emirates.

Britain’s biggest pharmaceuticals group confirmed the investigation following allegations of improper payments set out in a whistleblower’s email sent to its top management on Monday. The email, purporting to be from a GSK sales manager in the Gulf state, was seen by Reuters.

The company is already investigating alleged bribery in a number of Middle East countries, including Lebanon, Jordan, Syria and Iraq, as well as Poland.

“As we have already said, we are undertaking an investigation into our operations in the Middle East following complaints made previously. This investigation continues and these specific claims were already being investigated as part of this process,” a GSK spokesman said.

GSK and other major drugmakers are under increased scrutiny in the wake of the high-profile Chinese case and law enforcement agencies in both the United States and Britain are clamping down on overseas corruption by multinational companies.

The China scandal has hit GSK’s drug sales in the country and tarnished the reputation of Chief Executive Andrew Witty.

Other pharmaceutical companies, too, are in the firing line for alleged improper sales behavior.

France’s Sanofi said on Monday it had informed U.S. authorities of allegations of improper payments by its employees to healthcare professionals in East Africa and the Middle East.

Novartis, meanwhile, has been ordered to face a U.S. government lawsuit accusing the Swiss drugmaker of paying multimillion-dollar kickbacks.

And two women in Poland have pleaded guilty to bribery in another case involving an unnamed company.

In the case involving GSK’s practices in the UAE, the anonymous author of the email claimed that the British company made direct payments to healthcare professionals, hospitals, clinics and pharmacies to secure business.

This included payments for educational meetings — regardless of whether or not they took place — as well as schemes to pay customers for taking prescription drugs by giving them bonus over-the-counter products, the author said.

“We have zero tolerance for unethical behavior and we welcome people speaking up if they have concerns about alleged misconduct. We are committed to taking any disciplinary actions resulting from the findings,” the GSK spokesman said.

Does Prince Harry Know About GSK’s long History Of Unethical And Immoral Behavior?


images

WellChild13_L-407

GSK get a lot of publicity, and corporate brownie points, for sponsoring award ceremonies such as the BMJ lifetime achievement award, and the recent 2014 ‘Wellchild’ awards. There is nothing inherently wrong and unethical about corporate sponsorship of these types of events, but I must say, considering GSK’s appallingly unethical and sinister history (in particular in relation to harming children and babies) is there not something quite hypocritical about their sponsorship of awards relating to the well being of children?

It is understandable that Wellchild probably need to take GSK money in order to keep their organization afloat, but surely the stories of the children that GSK have harmed should also be highlighted?

England’s Prince Harry attended the recent Wellchild awards, most likely in very good faith, but perhaps if he was aware of GSK’s corporate history, he might not be so eager to support it? Many people who took GSK drugs such as Avandia, and Seroxat, ended up far from well-children or well-adults. Through deception, greed, and dodgy drugs GSK has made many children and adults quite ill, and in some cases GSK drugs have led to deaths.

GSK’s Seroxat was prescribed off label to tens of thousands of children worldwide, until a series of BBC Panorama documentaries exposed its links to increases in suicide, hostility, self harm and aggression, particularly in young adults and children. We will never know how many kids killed themselves on Seroxat (Paxil) but at least now it comes with a black box warning and is banned for under-18’s. However, GSK still have yet to apologize to all those harmed from this horrific drug and as far I am aware no UK victims, or their families, have been compensated for Seroxat damage. Maybe Prince Harry would care to check out some of the BBC’s Seroxat documentary series here and he can make up his own mind about GSK’s nefarious and dubious activities :

I could list endless examples of horrendously unethical behavior by GSK over the last few decades; behaviour which damaged and killed people of all ages; and this blog alone provides ample reading on that subject.  However, I think the  US department of Justice complaint (which led to GSK’s record breaking 3 billion fine in 2012) gives more than enough scope and numeous examples of the unscrupulously evil acts that this pharmaceutical company has committed in the pursuit of profits.

Maybe Prince Harry and Wellchild could look for a more ethical sponsor, or maybe they just don’t give a damn, who knows?

See the complaint here :

http://www.justice.gov/opa/documents-and-resources-july-2-2012-glaxosmithkline-gsk-press-conference


WellChild
WellChild is the national charity for sick children and is committed to ensuring that every child in the UK, no matter what their situation, location or diagnosis, has the very best possible quality of care.
Wehave supported this organisation since 2007
During 2013:
GSK donated £380,000
for the ongoing support of the WellChild Nurse programme and
in support of the annual WellChild Awards.
During 2012:
GSK donated £165,000 in support of WellChild’s
Nurse Programme, enabling the
employment of three nurses for three years.
GSK donated £54,242, to match money raised by Senior Managers of GSK in support of
WellChild’s work.
GSK donated £30,000 to assist with the 2013 Helping Hands fundraising event.
GSK donated £100,000 to support the 2013 WellChild Awards event.
Our support represented 16.1% of their overall income.
During 2011:
GSK provided support of £165,000 for the WellChild Children’s Nurse programme.
GSK provided funding of £10,000 in
support of the Medicines for Children website.
GSK donated £10,000 to support the 2011 WellChild Awards.
GSK provided £5,000 in support of the GSK Run For Good event.
During 2010:
GSK
donated £330,000 in support of the WellChild Children’s Nurse programme
GSK
donated £10,000 in support of the Medicine’s Information for Parents Project.
GSK
donated £8,000 to support two categories at the 2010 WellChild Awards.
Our support represented 21% of their overall income.
During 2007:
GSK gave a charitable donation
of £150,000 to fund a 3 year research programme
entitled ‘Identification of Autosomal Recessive Disease Genes by Autozygosity Mapping’
with Dr Neil Morgan at the University of Birmingham
Our support represented 5% of their overall income.

UK firm tried HIV drug on orphans

GlaxoSmithKline embroiled in scandal in which babies and children were allegedly used as ‘laboratory animals’

Orphans and babies as young as three months old have been used as guinea pigs in potentially dangerous medical experiments sponsored by pharmaceutical companies, an Observer investigation has revealed.

British drug giant GlaxoSmithKline is embroiled in the scandal. The firm sponsored experiments on the children from Incarnation Children’s Centre, a New York care home that specialises in treating HIV sufferers and is run by Catholic charities.

The children had either been infected with HIV or born to HIV-positive mothers. Their parents were dead, untraceable or deemed unfit to look after them.

According to documents obtained by The Observer, Glaxo has sponsored at least four medical trials since 1995 using Hispanic and black children at Incarnation. The documents give details of all clinical trials in the US and reveal the experiments sponsored by Glaxo were designed to test the ‘safety and tolerance’ of Aids medications, some of which have potentially dangerous side effects. Glaxo manufactures a number of drugs designed to treat HIV, including AZT.

Normally trials on children would require parental consent but, as the infants are in care, New York’s authorities hold that role.

The city health department has launched an investigation into claims that more than 100 children at Incarnation were used in 36 experiments – at least four co-sponsored by Glaxo. Some of these trials were designed to test the ‘toxicity’ of Aids medications. One involved giving children as young as four a high-dosage cocktail of seven drugs at one time. Another looked at the reaction in six-month-old babies to a double dose of measles vaccine.


http://www.independent.ie/irish-news/victim-reveals-horror-of-vaccine-trials-secret-legacy-26674008.html

Hundreds of children are feared to have been subjected to the experimental trials while in the care of the Catholic Church.

Now the victims’ cases could be reopened, as calls for the Government to deal with the scandal intensifies.

Legal action is being planned against GlaxoSmithKline and the Sacred Heart Order, which allowed the tests at the Bessborough Mother and Baby Home in Cork.

Campaigner and abuse survivor John Barrett, who was born at the home outside Cork city, was used as a ‘human guinea pig’ while in Lota industrial school, also in Cork.

“We didn’t have a clue what was being done to us at the time,” he said. “We only found out years later.”

John, now 58, wants to know the truth behind the children’s ordeal, who conducted the tests and why such experiments were allowed.

Hundreds of youngsters in children’s homes are believed to have been used in trials in the Sixties and Seventies to improve vaccines for tetanus, diphtheria and whooping cough.

John was used in four different experiments when he was aged 12 and 13 at the Lota home.

He said: “All of the boys of my age were taken off and given tests, X-rays and general examinations.

“Lists were made of those deemed to be ‘healthy’ and we would sometimes be lined up in one of the dormitories and given massive injections.

“We didn’t know what we were being given. Later blood tests would be taken and those whose scars from the first injection had disappeared were given a second dose.

“Over a couple of years, this happened about four times. I don’t think they were the normal injections you would expect.

“There is a major inquiry into child abuse so there should be a similar inquiry set up alongside it into medical experiments on children.”

More than 25,000 youngsters spent time in Irish orphanages between 1960 and 1975, the period when the controversial one-in-four trials are believed to have taken place.

Kevin Cooney of the Adopted And Fostered Persons’ Association said: “These orphans were society’s most innocent and vulnerable people.

“The State participated in abusing the rights of children in their care. That is indefensible. There must be a full disclosure.”

Meanwhile Health Minister Mary Harney has been called on to instruct her officials to make available all relevant information regarding the ongoing vaccine trials.

The call comes following Mari Steed, 50, breaking her silence on Friday, in the Irish Independent, into how she was subjected to a controversial vaccine trial as a baby without her mother’s consent.

She said she the trial were carried out on her between December 1960 and October 1961, when she was between nine and 18 months old.

Ms Steed, who now lives in the US, and three others, are preparing to take legal action in US courts against the drugs company, GlaxoSmithKline.

Leas Ceann Comhairle Brendan Howlin, who was health minister in 1993, assured victims that an inquiry had found they suffered no ill effects from the experimental medical tests.

He admitted he did not remember the probe or its findings. The Department of Health said it was searching department archives in a bid to locate the documents.

Mr Reilly said yesterday that all the facts must be put on the table.

“It is totally unacceptable for children in the care of the State to be involved in a vaccine trial without proper information being made available, or the full consent of their parents or guardians.”

Sunday Independent

- See more at: http://www.independent.ie/irish-news/victim-reveals-horror-of-vaccine-trials-secret-legacy-26674008.html#sthash.XEdUjOqq.dpuf


 http://www.theargus.co.uk/archive/2003/09/24/5103769.Happy_pill_girl_s_suicide_tragedy/

Happy pill girl’s suicide tragedy

A brilliant young artist killed herself after taking the controversial anti-depressant Seroxat.

Sharise Gatchell, 18, had been prescribed the drug without her parents’ knowledge.

They found her body when they returned home after a weekend away.

Sharise had hanged herself. A packet of Seroxat, with 30 empty blisters, was lying on her bed.

Today her father Alfred said he blamed the so-called wonder drug for her death.

He and wife Stephanie, of Lawes Avenue, Newhaven, have joined calls for it to be banned.

A coroner at Eastbourne yesterday stopped short of making a definite link.

But he said he would pass the findings of the inquest to the Committee on the Safety of Medicines, the Government’s advisory body on pharmaceuticals.

Sharise’s death is the latest in a series of cases brought to the attention of the pill’s Crawley-based manufacturer, GlaxoSmithKline (GSK). It insists the drug, which has become the most heavily-prescribed anti-depressant since it was first licensed in 1990, is safe.

The inquest heard Sharise, an “extremely talented” art foundation student at City College, Brighton, was initially prescribed Seroxat to help her battle shyness and depression.

But her condition deepened and she experienced dramatic mood swings, withdrawing into herself.

She agreed with her parents to come off the drug.

However, shortly before her death she was given a new prescription without the knowledge of her parents.

Mr and Mrs Gatchell went away on Friday, May 23, believing Sharise’s best friend was staying for the weekend.

Her parents returned early on Monday, May 26, to find their daughter’s body.

The empty pack of pills, dated May 7, a blood-stained craft knife and a note were on her bed.

Mrs Gatchell told the inquest: “I had no idea she was on Seroxat but she was definitely behaving very strangely. Had we known she was taking it we would never have gone away.

“She was aggressive, hostile and very depressed.

“We feel cheated that as a family we didn’t know she had been prescribed Seroxat just because she was over 16.

“We as parents should have been able to have had some input even if we could not have stopped her. With all the controversy surrounding it, why take the risk?”

Sharise’s GP, Dr Zoe Nunn, of the Quayside Medical Practice in Chapel Street, Newhaven, said she had no fears about prescribing Sharise Seroxat.

She said: “I felt she was quite chirpy and didn’t have any serious concerns.

“If I had had concerns she was at risk of self-harm or suicide I would have made sure she was followed up more closely.”

East Sussex coroner Alan Craze recorded a verdict of suicide.